Prostate cancer incidence among distant relatives on both sides of a man’s family can help predict whether he will develop the disease, according to a recent study published in the journal Prostate.
Researchers from the University of Utah discovered that family history was just as effective at predicting disease incidence as the prostate-specific antigen (PSA) test, a common screening test for prostate cancer. While the screening test increased the number of diagnoses, the proportion of cases associated with family history remained the same before and after the advent of the PSA test.
After analyzing genealogic and medical data of 7.3 million individuals, authors of the study observed that two-thirds of Utah men have some increased risk of developing prostate cancer due to family history.
Read more about the study and the findings here.
If you or a loved one is diagnosed with prostate cancer, contact Columbus CyberKnife to set up a prostate cancer consultation visit and learn more about noninvasive CyberKnife® treatment.
This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.